Expert: Sinopharm's COVID-19 vaccine can make a great contribution to the global vaccine rollout
CGTN, 31 Jan 2021
For more:
https://www.cgtn.com/video
Dr. Jerome H. Kim, director-general of the International Vaccine Institute, said the COVID-19 Vaccine Global Access (COVAX) expects to deliver at least 2 billion doses of vaccine by the end of this year, which is unprecedented in history. He hoped that after Sinopharm's COVID-19 vaccine is approved by the World Health Organization, it can make a great contribution to the global vaccine rollout by taking advantage of its production capacity. He said COVAX understands the efficacy and safety of the Sinopharm vaccine.
Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
https://www.cgtn.com/video
Dr. Jerome H. Kim, director-general of the International Vaccine Institute, said the COVID-19 Vaccine Global Access (COVAX) expects to deliver at least 2 billion doses of vaccine by the end of this year, which is unprecedented in history. He hoped that after Sinopharm's COVID-19 vaccine is approved by the World Health Organization, it can make a great contribution to the global vaccine rollout by taking advantage of its production capacity. He said COVAX understands the efficacy and safety of the Sinopharm vaccine.
Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
